Financial Penalties in Regulatory Compliance

Authors

  • Durga Lakshmi.S, Raghava.D, Nageswara Rao.K, Naga Sravani.P Author

DOI:

https://doi.org/10.48047/

Keywords:

Regulatory Compliance, Financial Penalties, Pharmaceutical Industry, FDA, EMA, CDSCO, Quality Framework, Risk Mitigation

Abstract

Regulatory compliance is a cornerstone of the pharmaceutical industry, ensuring that drugs are developed, manufactured, and marketed in accordance with safety, efficacy, and quality standards. However, non-compliance with regulatory

Downloads

Download data is not yet available.

Downloads

Published

2025-10-07

Issue

Vol. 16 No. 10 (2025): Volume 16 Issue 10 (2025)

Section

Articles